Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cetuximab sarotalocan - Rakuten Medical

Next Previous
X
Search
Drug Profile

Cetuximab sarotalocan - Rakuten Medical

Alternative Names: Akalux; ASP-1929; Cetuximab-IR700; RM-1929

Latest Information Update: 23 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Aspyrian Therapeutics
  • Developer National Cancer Center Hospital East; Rakuten Medical
  • Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies
  • Mechanism of Action Cell death stimulants; Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Head and neck cancer
  • Phase II Squamous cell cancer
  • Phase I Oesophageal cancer
  • Preclinical Cancer
  • No development reported Gastric cancer

Most Recent Events

  • 19 Aug 2024 Rakuten Medical plans a phase II trial for Head and neck cancer (Recurrent, First -line therapy, Combination therapy) (IV) in 2H of 2024
  • 31 May 2024 Efficacy and adverse events data from a phase Ib/II trial in Squamous cell cancer presented at the 60th Annual Meeting of the American Society of Clinical Oncology, 2024(ASCO-2024)
  • 24 May 2024 Efficacy and adverse events data from phase I/II trials in Squamous cell cancer released by Rakuten Medical

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top